Is Navios Maritime Partners (NMM) a Great Stock for Value Investors?

Cornelia Mascio
Января 20, 2018

It has outperformed by 17.63% the S&P500.The move comes after 8 months negative chart setup for the $343.10 million company. We have $2.19 PT which if reached, will make NYSE:NMM worth $13.72M less. One analyst has rated the stock with a sell rating and three have issued a hold rating to the stock. The stock of Lipocine Inc. The firm has "Buy" rating by Jefferies given on Monday, October 23. JP Morgan maintained the shares of SNE in report on Sunday, August 16 with "Overweight" rating. Canaccord Genuity downgraded Lipocine Inc. The rating was maintained by Stifel Nicolaus with "Hold" on Thursday, June 22. H.C. Wainwright initiated Ocera Therapeutics, Inc. (NYSE:IT) on Wednesday, April 12 with "Buy" rating.

More notable recent Navios Maritime Acquisition Corporation (NYSE:NNA) news were published by: which released: "Navios Maritime Acquisition Corporation (NNA) Ex-Dividend Date Scheduled for ..." on December 04, 2017, also with their article: "Navios Maritime Acquisition's (NNA) CEO Angeliki Frangou on Q2 2017 Results ..." published on August 11, 2017, published: "Why Teekay Corp., Teekay Offshore, and Navios Maritime Acquisition Stock ..." on June 07, 2017. Stifel Nicolaus has "Buy" rating and $2.25 target. The stock has "Underperform" rating by Wells Fargo on Friday, March 11. A stock rating will usually tell the investor how well a stock's market value relates to what analysts believe is a fair value for the stock, based on an objective evaluation of the company. The firm offers a portfolio of proprietary product candidates created to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The consensus mean EPS for the current quarter is at $0.02 derived from a total of 5 estimates from the analysts who have weighed in on projected earnings.

The stock increased 0.69% or $0.06 during the last trading session, reaching $8.76. About 174,757 shares traded. Lipocine Inc. (NASDAQ:LPCN) has declined 54.30% since January 17, 2017 and is downtrending. It has underperformed by 21.30% the S&P500.

Navios Maritime Partners LP (NYSE:NMM)'s revenue estimates for the current quarter are $56.22 Million according to 4 number of analysts, for the current quarter the company has high revenue estimates of $60.7 Million in contradiction of low revenue estimates of $52 Million. They expect $0.02 earnings per share, down 77.78 % or $0.07 from last year's $0.09 per share. NMM's profit would be $3.02M giving it 27.88 P/E if the $0.02 EPS is correct.

Taking a broader look at the analyst consensus, brokerage firms have a price target of $13.3 on Navios Maritime Holdings Inc (NYSE:NM).

Navios Maritime Midstream Partners L.P. owns, operates, and acquires crude oil tankers, refined petroleum product tankers, chemical tankers, and liquefied petroleum gas tankers. The company has market cap of $343.10 million.

According to Zacks, "Navios Maritime Holdings a seaborne shipping and logistics company engaged in the transport and transshipment of drybulk commodities including iron ore, coal and grain". The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 460. The Company's fleet comprises 12 Panamax vessels, 9 Capesize vessels, 3 Ultra-Handymax vessels, and 7 container vessels.

Analysts have given a mean recommendation of 2.40 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Therefore 43% are positive. Institutional investors own 10.85% of the company's stock.

On the other hand the company has Relative Strength Index (RSI 14) of 49.22 along with Average True Range (ATR 14) of 0.1, Consequently Navios Maritime Partners LP (NYSE:NMM)'s weekly and monthly volatility is 5.09%, 3.79% respectively. Stifel Nicolaus maintained the shares of NMM in report on Thursday, August 31 with "Hold" rating. JP Morgan downgraded Navios Maritime Partners L.P. (NYSE:NMM) on Wednesday, January 17 to "Neutral" rating. The firm has "Buy" rating given on Friday, October 13 by BMO Capital Markets. TheStreet raised shares of Navios Maritime Midstream Partners from a "d+" rating to a "c" rating in a report on Monday, November 13th.

Altre relazioni

Discuti questo articolo

Segui i nostri GIORNALE